TFAM and glioblastoma: Consistent with transcriptomic findings, TFAM protein levels were significantly lower in GBM than in AG2 (p = 0.0151) and AG3 (p < 0.0001; one-way ANOVA, Kruskal–Wallis test with Dunn’s post hoc test).